Cell And Gene Therapy Manufacturing Market

Cell And Gene Therapy Manufacturing Market Size, Share, Growth Analysis, By Therapy Type(Cell therapy manufacturing, Gene therapy manufacturing), By Scale(Pre-commercial/ R&D scale manufacturing, Commercial scale manufacturing), By Mode(Contract manufacturing, In-house manufacturing), By Workflow(Cell processing, Cell banking), By Regional(North America, Europe) - Industry Forecast 2024-2031


Report ID: UCMIG35H2171 | Region: Global | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

Cell And Gene Therapy Manufacturing Market Insights

Market Overview:

The global cell and gene therapy manufacturing market experienced significant growth in 2022, with a valuation of USD 7.28 billion. This market is projected to maintain a robust compound annual growth rate (CAGR) of 26.6% from 2023 to 2030. The increasing demand for innovative and personalized treatment options, along with advancements in biotechnology, are key factors driving this growth. The emergence of groundbreaking cell and gene therapies, coupled with favorable regulatory frameworks, is expected to further propel the market expansion in the coming years. As a result, the cell and gene therapy manufacturing industry is poised for substantial growth and transformative impact on the healthcare sector.

Cell And Gene Therapy Manufacturing Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
ForecastGrowthRate
To get more reports on the above market click here to
Get Free Sample

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Biotechnology by segment aggregation, the contribution of the Biotechnology in Pharmaceuticals, Biotechnology & Life Sciences and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The market for Cell And Gene Therapy Manufacturing was estimated to be valued at US$ XX Mn in 2021.

The Cell And Gene Therapy Manufacturing Market is estimated to grow at a CAGR of XX% by 2028.

The Cell And Gene Therapy Manufacturing Market is segmented on the basis of Therapy Type, Scale, Mode, Workflow, Regional.

Based on region, the Cell And Gene Therapy Manufacturing Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the Cell And Gene Therapy Manufacturing Market are Lonza, Bluebird Bio Inc., Catalent Inc., F. Hoffmann-La Roche Ltd., Samsung Biologics, Boehringer Ingelheim, Cellular Therapeutics, Hitachi Chemical Co., Ltd., Bluebird Bio Inc., Takara Bio Inc., Miltenyi Biotec, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, Novartis AG, Merck KGaA, Wuxi Advanced Therapies.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Cell And Gene Therapy Manufacturing Market

Product ID: UCMIG35H2171

$5,300
BUY NOW GET FREE SAMPLE